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Indirect evidence against a role of the kinin system in the
renal hemodynamic effect of captopril in the rat
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Indirect evidence against a role of the kinin system in the renal
hemodynamic effect of captopril in the rat. The effects of acute
saralasin (SAR) and captopril (SQ) administration on arterial
pressure (AP), plasma renin activity (PRA), urinary excretion of
water and electrolytes, glomerular filtration rate (GFR), renal
blood flow (RBF), and glomerular blood flow (GBF) distribution
(microsphere technique) were assessed in rats with activation of
the renal renin and kallikrein systems (that is, chronic sodium
depletion). In both groups AP decreased, and PRA and RBF in-
creased markedly. Blood flow to outermost (C1) glomeruli was
(in nl/min/g of kidney wt) 270 35 in SAR and 219 20 in the SQ
group (NS when compared to 208 9 in control chronically so-
dium-depleted rats). Blood flow to innermost glomeruli (C4)
strikingly increased from 95 10 (control) to 216 21 (SAR) and
180 13 (SQ group). Hence, preferential vasodilatation of in-
nermost glomeruli occurred (C11C4 ratio of 2.18 0.27 in control,
1.26 0.11 in SAR, and 1.25 0.07 in SQ rats). Chronic (6 days)
administration of SQ was associated with a rapid and marked
increase in water and sodium excretion. At the end of the study,
RBF was higher than control, and GBF distribution was similar
to that observed in acutely treated rats (C1/C4 ratio of 1.16
0.10). These results suggest that angiotensin plays a significant
role in the systemic and renal hemodynamic changes associated
with chronic sodium depletion. The similarity of the changes in-
duced by SAR and SQ provides an indirect evidence against an
effective role of the renal kallikrein system in the effect of capto-
pril.
Argument indirect contre le role du système kallicréine-kinine
dans l'effet hémodynamique renal du captopril. Les effets de
l'administration aiguë de saralasine (SAR) et de captopril (SQ)
sur la pression artérielle (AP), l'activité rénine plasmatique
(PRA), l'excrétion urinaire de l'eau et des electrolytes, le taux de
filtration glomérulaire (GFR), le flux sanguin renal (RBF), et la
distribution (technique des microsphères) des flux sanguins
glomCrulaires (GBF) ont été estimés chez des rats dont les sys-
tèmes rénine-angiotensine et kallicréine rénaux ont été activés
par Ia déplétion sodée chronique. Dans les deux groupes (SAR et
SQ), la AP a diminué et I'PRA et le RBF ont augmenté de facon
similaire. Le flux sanguin des glomérules les plus superficiels
(C1) (en nllmin/g rein) était de 270 35 chez les animaux du
groupe SAR et 219 20 dans le groupe SQ (NS par rapport a Ia
valeur 208 9 du groupe de rats contrôles déplétés chronique-
ment en sodium). Le flux des glomérules les plus profonds (C4)
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augmente de façon nette de 95 10 (contrOle) a 216 21 (SAR)
et a 180 13 (SQ). Ces résultats suggèrent une vasodilatation
préférentielle des glomerules profonds (rapport C1/C4 de 2.18
0.27 pour le groupe contrOle, 1.26 0.11 pour le groupe SAR, et
1.25 0.07 pour les rats traités par SQ). L'administration chro-
nique (6jours) de SQ a été associée a une augmentation rapide de
l'excrétion d'eau et de sodium. A la fin de I'étude le RBF était
supérieur a Ia valeur contrOle et Ia distribution des GBF était
semblable a celle observée chez les animaux traités en aigu (rap-
port C1/C4 = 1.16 0.10). Ces résultats suggèrent que l'angio-
tensine joue un rOle significatif dans les variations hémodynam-
iques systémiques et rénales associées a la déplétion sodée
chronique. La similarité des modifications induites par SAR
et SQ constitue un argument indirect contre la mediation des ef-
fets du captopril par le systéme kallicréine-kinine renal.
Interpretation of the effects of the inhibition of
endogenous activity of the renin-angiotensin system
by either specific angiotensin II antagonists or in-
hibitors of angiotensin-I-converting enzyme (CEI)
is complicated by the fact that the observed con-
sequences may not be the result of the sole inhibi-
tion of endogenous angiotensin. Estimation of the
effects of saralasin, the most widely used angioten-
sin blocker, and the converting enzyme inhibitor
(SQ 20881) in hypertensive patients [1] and in so-
dium-depleted rats [2] showed that the blood-pres-
sure-lowering action of CE! was more marked than
was that of saralasin. Because saralasin is known to
induce systemic [1, 3] and renal vasoconstriction [3,
4] in states associated with depressed or normal re-
nm level and CE! also inhibits the major bradykinin
degradation enzyme kininase II [5], it was sug-
gested that the role of angiotensin is underestimated
when saralasin is used [1] or that bradykinin accu-
mulation participates in the response to CEI. Stud-
ies of the changes in plasma bradykinin concentra-
tion during CEI administration have yielded con-
troversial observations [6—8]. Moreover, it has
never been demonstrated that observed changes in
plasma bradykinin have a systemic or renal vasodi-
lating effect per Se. In addition, an effect of kinin at
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the site of generation cannot be excluded because
the kidney is an important source of kallikrein (re-
nal tissue kallikrein decreasing progressively from
the outer to the inner cortex [9]) and of kininase ac-
tivity [10].
In the present studies, the acute effects of sarala-
sin and the CEI captopril (SQ 14225) [ii] on arterial
pressure, plasma renin activity, sodium excretion,
renal blood flow and its intracortical distribution
were compared in chronically sodium-depleted rats.
The rationale of the study was based on the facts
that saralasin has no agonistic effect in the rat even
at doses up to 100 g/minJkg [12] and that the renal
kallikrein-kinin system is highly activated by chron-
ic sodium depletion [13, 14]. Hence, if kinins partic-
ipate to the intrarenal effects of captopril, a pattern
of glomerular blood flow distribution different from
that induced by saralasin would be observed. In a
separate study, consequences of chronic captopril
administration were assessed.
The results of the present investigation indicate
that both inhibitors had similar effects on all param-
eters, thus suggesting that captopril probably acts
solely through inhibition of the renin-angiotensin
system, at least in the rat.
Methods
Studies were conducted in 47 male Sprague-Daw-
ley rats, each weighing 280 to 480 g, that were fed a
low sodium diet containing less than 5 mmoles of
sodium per kilogram of chow for 4 weeks prior to
the experiments. The effect of two inhibitors of the
renin-angiotensin system (saralasin and captopril)
on systemic and renal hemodynamics was assessed
in 37 rats, and the effect of these agents on renal
function was studied in a separate series of experi-
ments (10 rats).
Hemodynarnic studies. All rats were anesthetized
with sodium pentobarbital (30 mg/kg of body wt,
i.p.). An airway was provided by tracheostomy,
and catheters (PE 50, Clay Adams) were placed into
the left ventricle (for microsphere administration), a
femoral artery (for continuous arterial pressure re-
cording and arterial sample collections), and a jugu-
lar vein (for drug or vehicle administration and
venous blood collections).
After arterial pressure had stabilized, an i.v. in-
fusion of either the vehicle (control group, N = 15)
or saralasin dissolved in a 5% dextrose solution (sa-
ralasin group, N = 9) was given at a rate of 0.0116
mi/mm. Saralasin was administered at a dose of 5
gImin/kg for 30 mm prior to hemodynamic deter-
minations. In a group of 8 rats, hemodynamic stud-
ies were performed 45 to 60 mm after the oral ad-
ministration of captopril at a dose of 2.5 mg through
an intragastric cannula (acute captopril group).
Venous blood samples were obtained before and af-
ter the administration of inhibitors for the determi-
nation of plasma renin activity.
In addition, the effect of chronic (6 days) treat-
ment by captopril (5 mg at 10:00 A.M. and 6:00 P.M.
mixed with food and a drinking fluid containing 0.1
mg/ml of captopril) on systemic and renal hemo-
dynamics was assessed in 5 rats (chronic captopril
group). Rats of this latter group were placed in
metabolic cages, and daily urine volume and so-
dium and potassium excretion were determined be-
fore and during captopril administration.
Hemodynamic parameters were assessed by ra-
dioactive microspheres with a mean diameter of 15
5 pm (3M Co., St Paul, Minnesota). Briefly,
50,000 microspheres suspended in 0.5 ml of a su-
crose solution were infused over 20 to 30 sec into
the left ventricle, and blood was simultaneously
withdrawn from the femoral artery at a constant
rate of 1.18 mI/mm with a motor-driven syringe
(Harvard Apparatus). Following the administration
of microspheres, 1 ml of a 10% alcian blue solution
was injected into the left ventricle to stain the
glomeruli. This injection was followed shortly by
the death of the animals. The kidneys were then re-
moved and placed into a 25% ethanol solution to
count the radioactivity. Subsequently, the kidneys
were cut into approximately 200 gm-thick sagittal
sections, which were dehydrated by exposure to ab-
solute ethanol and cleared with methyl salicylate for
microscopic examination.
Analysis of tissue sections with a camera lucida
and a grid system provided an estimation of the dis-
tribution of glomeruli and microspheres in four cor-
tical zones (C1 to C4) of equal thickness between the
capsule and the deepest glomeruli. Kidney slices
were analyzed until at least 400 spheres were
counted in each animal [15]. Thus, in each rat total
blood flow and the distribution of micro spheres and
glomeruli within renal cortex were estimated.
Cardiac output (CO) was calculated as (R X 1.18)!
r, where R is the amount of radioactivity injected
and r is the radioactivity of the reference sample. Re-
nal blood flow (RBF) was calculated as (K X 1.18)!
r, where K is the radioactivity per gram of kidney
tissue. Blood flow per glomerulus (GBF) was calcu-
lated as (TRBF x M)!(33,000 X G), where TRBF is
the total blood flow to the kidney analyzed, M and
G are the percentages of microspheres and glomer-
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uli, respectively, in each of the four cortical zones,
and 33,000 is the average number of glomeruli per
kidney of weight-matched rats (personal results).
Effect of acute angiotensin blockade on renal
function. In separate studies, the effect of acute ad-
ministration of saralasin (N = 6) and captopril (N =
4) on urinary excretion of water and electrolytes
and GFR (clearance of 1251-sodium iothalamate esti-
mated by the continuous infusion technique) was
assessed. After a 1-hour equilibration period, two
15-mm control urine collections were obtained
through a bladder catheter. Subsequently (30 mm
after the administration of the inhibitors), urine was
collected for two 15-mm periods. The average of
values obtained during control and experimental pe-
riods was used.
Analytical methods. Plasma renin activity was
determined by radioimmunoassay (CEA Sorin Kit).
No exogenous rat substrate was added before in-
cubation. Urine sodium and potassium concentra-
tions were determined by flame photometry. All
values were expressed as the means SEM. Dif-
ferences between mean values were tested by the
Wilcoxon Rank Sum Test or the Student's t test
where appropriate.
Results
Characteristics of chronically sodium-depleted
rats (Table 1 and Fig. 1). Mean values of mean arte-
rial pressure, body weight, cardiac output, and re-
nal blood flow are summarized in Table 1.
Results of microscopic analysis of cleared kidney
slices were obtained by observation of mean values
of 463 51 microspheres and 641 21 glomeruli
per rat. In the group of chronically sodium-depleted
rats, the percentages of microspheres and glomeruli
found within each layer were, respectively, 44.0
1.1 and27.7 0.8forC1, 30.1 0.9and33.8 0.8
for C2, 17.7 1.2 and 25.4 0.4 for C3, and 9.0
0.6 and 13.2 0.8 for C4. Thus, microsphere den-
sity clearly exceeded that of glomeruli only in the
outermost one fourth of the renal cortex; the ratio
of microsphere (in percent of total) to glomeruli dis-
tribution (in percent of total) was 1.64 0.6 in C1
and 0.71 0.06 in C4. Apparent glomerular blood
flows (nanoliters per minute per gram of kidney)
calculated as described in the method section yield-
ed the mean values shown in Fig. 1; blood flow to C1
glomeruli was higher than that to other glomeruli,
but flows to C3 and C4 glomeruli were quite similar.
The ratio of blood flow of outermost (C1) to that of
innermost (C4) glomeruli was 2.18 0.27.
Effect of acute blockade of the renin-angiotensin
system in low-sodium rats. As shown in Fig. 2, sara-
lasin infusion and acute captopril administration in-
duced a similar decrease in mean arterial pressure
(—17.5 3.7 and —15.5 2.3 mm Hg, respectively)
and an identical increase in plasma renin activity.
Cardiac output was not altered by acute blockade of
the renin-angiotensin system; total peripheral resis-
tance was lower, however, than control in saralasin
and acute captopril groups (Table 1).
Renal blood flow was higher than control in sara-
lasin- (P < 0.01) and captopril-treated rats (P <
0.05); no significant difference between saralasin
and acute captopril groups were observed, how-
ever (Table 1).
Analysis of cleared kidney slices showed that the
ratio of microsphere (in percent of total) to glomer-
Table 1. Hemodynamic data in saralasin and SQ 14,225-treated sodium-depleted rats
Low sodium control
(N = 15)
Saralasin
(N = 9)
Acute SQ 14,225(N = 8)
Chronic SQ 14,225(N = 5)
Mean arterialpressure, mm Hg
Body wt,g
Cardiac output, mi/kg/mm
Renal bloodflow,mI/glmin
130.0 4.9
321 9
200 12
4.5 0.3
113.4 5.4
364 6
231 10
6.35 0.7"
115.1 5.6
369 13
183 11
5.6 0.5"
113.7 5.5
354 8"
244 20
7.15 0.8"
"Comparison with low-sodium control animals was made by Student's t test (P <0
.05).
50
Glomeruli
4o
Inner fourthOuter of cortex
Microspheres)% of total) 164 0.89 0.66 0.71
Glomeruli (% of total) 0.06 0.02 0.04 0.06
Glornerular blood flow 208 9 114 6 86 8 95 10
ni/mm per g kidney
Fig. 1. Distribution of glomeruli and microspheres and single
glomerular blood flows in chronically sodium-depleted rats.
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Fig. 2. Changes in mean arterial pressure (MAP) and plasma
renin activity (PRA) induced by acute administration of sarala-
sin and captopril (SQ /4225).
uli distribution (in percent of total) decreased sig-
nificantly (P < 0.005) from 1.64 0.06 in control
rats to 1.29 0.04 and 1.30 0.3 in saralasin and
captopril groups, respectively, for the superficial
zone (C1), did not vary drastically in zone C2, and
increased for C3 and C4 layers; the C4 ratio being
higher (P < 0.005) than control in saralasin (1.07
0. 1) and captopril(l.07 0.05) groups. As shown in
Fig. 3, calculated blood flow of outermost glomeruli
was not significantly altered by both agents, where-
as that of C2, C3, and C4 glomeruli was higher than
control. Blood flow of innermost glomeruli (C4) in-
creased from 95 10 nllminlg of kidney (control
group) to 216 21 (P < 0.001, saralasin) and 180
13 (P < 0.001, acute captopril group). The ratio of
C1 to C4 glomerular blood flow was 1.26 0.11 and
1.25 0.07 in saralasin and acute captopril groups,
respectively (P < 0.001 and P < 0.025 when com-
pared with the mean value of 2.18 0.27 found in
control rats). No difference between the groups
acutely treated by angiotensin inhibitors was ob-
served.
The effects of both inhibitors on renal function
are summarized in Table 2.
Acute inhibition of the renin-angiotensin system
was thus associated with no change in natriuresis
and GFR, but renal blood flow increased markedly
together with redistribution of cortical flow to deep
glomeruli. The effects of saralasin and captopril
were similar.
Effect of chronic treatment by captopril. The
changes in urinary volume, urinary sodium excre-
tion, and urinary potassium excretion are shown in
Fig. 4. Captopril administration was rapidly fol-
lowed by an increase in urinary volume and sodium
excretion, whereas urinary potassium decreased.
Mean arterial pressure (113.7 5.5 mm Hg) was
significantly lower than the mean value obtained in
32 sodium-restricted rats (138.5 4.2, P < 0.05).
As shown in Table 1, cardiac output was not al-
tered, and renal blood flow was higher than control
but not different from the mean values obtained in
the other two groups. At the time of the study, the
arterial pressure response to a 100-ng bolus of angi-
otensin I was 2 1 mm Hg.
Data presented in Fig. 3 show that renal hemo-
dynamics changes associated with chronic captopril
treatment were identical to those observed after
acute inhibition of the renin-angiotensin system; in
this group, the ratio of C1 to C4 glomerular blood
flow was 1.16 0.1 (P < 0.02 compared with con-
trol group, but significantly different from values
obtained in the other two groups).
Discussion
In the present investigation conducted in anesthe-
tized, chronically sodium-restricted rats, inhibition
of the renin-angiotensin system at the receptor level
by saralasin or through blockade of angiotensin-con-
veiling enzyme by captopril resulted in identical
Table 2. Effects of acute administration of saralasin (N = 6)and captopril (N = 4) on mean arterial pressure (MAP),
urine volume (UV), sodium (UNaV), and potassium (U5V)
Control Saralasin P Control Captopril P
MAP,mmHg 130 4 ill 2 <0.05 127 6 116 6 <0.001
UV, p1/mm 3.7 0.6 5.9 0.7 < 0.05 4.6 1.2 3.9 0.6 NS
UNV,nmolesImin 77 38 57 23 NS 33 7 20 3 NS
UKV,nmoles/min 839 299 779 143 NS 276 79 352 150 NS
GFR,ml/min 2.5 0.6 1.9 0.3 NS 3.4 0.4 2.6 0.1 NS
140 • Saralasin
0 SQ 14, 225
120
100
80
140
120
I
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Fig. 4. ffect of chronic (6 days) oral administration of captopril
(SQ 14,225) on urine volume and sodium and potassium excre-
tion in low-sodium rats. Asterisks (*) denote P <0.05 compared
with pretreatment values.
hemodynamic changes. Arterial pressure de-
creased, and cardiac output did not change during
angiotensin blockade, thus suggesting that a reduc-
tion in total peripheral resistance occurred. In addi-
tion, renal blood flow increased together with a shift
of cortical blood flow from outermost to deep
glomeruli, because blood flow to outermost glomer-
uli (CI) did not change significantly whereas that to
the remaining three layers increased. No significant
difference between the effects of acute administra-
tion of saralasin and captopril on arterial pressure,
plasma renin activity, and intrarenal hemodynamics
was found. Moreover, chronic captopril treatment
was associated with hemodynamic changes similar
to those produced by acute administration of the
converting enzyme inhibitor. These results suggest
that captopril probably acts solely through inhibi-
tion of the renin-angiotensin system in the rat.
Acute and chronic inhibition of the renin-angio-
tensin system resulted in a significant decrease in
total peripheral resistance, thus suggesting that in
the rat chronic sodium deprivation is associated
with systemic vasoconstriction, which helps to
maintain a normal arterial pressure.
The decrease in total peripheral resistance and
the increase in renal blood flow associated with
acute and chronic inhibition of the renin-angioten-
sin system suggest that elevated circulating and in-
trarenal levels of angiotensin II mediate hemo-
dynamic responses to chronic sodium depletion in
the rat. This is in keeping with previous observa-
tions in rat [16—18], rabbit [4], dog [19], and man [3,
6]. With respect to the effect of low sodium diet on
renal blood flow, controversial results have been
obtained; some investigators using electromagnetic
flowmetry [18] or PAH clearance [20] found no dif-
ference, but others [16, 21] using radioactive micro-
spheres observed that renal blood flow is signifi-
cantly lower in rats chronically fed a low sodium
diet than it is in those given high amounts of sodium
for several weeks. The reason for these dis-
crepancies is not clearly understood although the
microsphere technique is known to provide an ac-
curate estimation of total renal blood flow [4, 22].
No studies have been reported to date on the ef-
fect of angiotensin inhibitors on intrarenal blood
flow distribution in sodium-deprived rats. The re-
sults of the present investigation indicate that acute
administration of saralasin or captopril, as well as
chronic captopril treatment, is associated with a
modest but not significant increase in blood flow to
outermost glomeruli (C1) and a blood flow to the
juxtamedullary (C4) glomeruli that is augmented and
actually more than doubled, which results in a sharp
decrease in the ratio of C1 to C4 glomerular blood
flow. As emphasized by several groups [22-24], in-
trarenal distribution of the widely used l5-tm mi-
crospheres may not accurately reflect the distribu-
tion of glomerular blood flow in rats on ad lib so-
dium intake. All reports indicate that l5-m spheres
tend to overestimate blood flow to superficial
300r
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200
A 1SaraIasin (N 6)
Acute SQ 14, 225(N— 8)
.
10:
C, C2
IControl (N 15)
Outer Inner fourth of cortex
Fig. 3. Glomerular blood flows in control and after acute and
chronic inhibition of the renin-angiotensin system in low-sodium
rats. Asterisks (*) denote P <0.05 compared with values ob-
tained in the control group. No significant difference between
saralasin and acute and chronic captopril groups was observed
by analysis of variance.
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glomeruli and underestimate that to juxtamedullary
glomeruli because rather unrealistic filtration frac-
tion values were obtained, ranging from 0.19 in the
outermost one third to 0.63 in the innermost one
third of cortex [23]. Several factors may contribute
to these inaccuracies and artefacts, including axial
streaming, steric hindrance of sphere movement
along interlobular arteries and anatomic factors.
The magnitude of the artefact related to axial
streaming is known to increase with the size of the
particle, larger spheres having more axial move-
ment [25], and the linear flow velocity through the
interlobular arteries [26]. This artefact may be mini-
mized when the ratio of sphere size to the diameter
of afferent arterioles of deep cortical glomeruli
tends to decrease; this could be achieved through
reduction in the microsphere diameter (in normal
rats, 10-gm spheres yield smaller estimates of flow
to outercortex and higher innercortical flow than do
l5-m spheres [22, 23]) and through hemodynamic
conditions associated with preferential dilatation of
the afferent arteriole of deep cortical glomeruli
(these conditions can only be suspected if the
change in total blood flow exceeds that of blood
flow to superficial glomeruli accessible to micro-
puncture technique). In the rat, afferent arterioles
branch off at an acute recurrent angle from the
proximal part of interlobular arteries, and the angle
of origin gradually opens out as the parent vessel is
followed peripherally until the final few afferent ar-
terioles are almost in line with the parent vessel
[27]. This anatomical pattern may prevent the mi-
crospheres from easily entering into deep glomeruli,
leaving them to be trapped preferentially in superfi-
cial glomeruli. Although these considerations sug-
gest that microsphere distribution does not accu-
rately reflect the distribution of glomerular blood
flow, the statement should be restricted to normal
rats because no critical analysis of the microsphere
method has been undertaken in low-sodium rats. In
a recent study conducted in chronically sodium-de-
pleted Munich-Wistat rats [28], blood flow of super-
ficial glomeruli was estimated at 229 nllminlg of kid-
ney, a value very close to that found in the present
studies (208 nllminlg of kidney). This suggests that
in chronically sodium-depleted rats, the artefacts
associated with the microsphere technique might be
minimized for reasons that remain to be defined. In
addition, it should be emphasized that in the present
studies glomerular blood flows were estimated from
the distribution of microspheres and glomeruli in
cortical layers obtained by microscopic observation
rather than from counting of radioactivity, a tech-
nique that may lead to inadequate estimation of gb-
merular blood flow distribution because radio-
activity is related to the volume of microspheres,
the largest ones tending to be trapped by superficial
gbomeruli [24].
In the studies of Steiner, Tucker, and Blantz [28],
paired determinations of superficial glomerular
blood flow before and during saralasin infusion
showed that a 20% increase in this parameter oc-
curred; although changes in this order of magnitude
were observed in our studies conducted in separate
groups of animals, statistical significance was not
reached. From a combination of the data of Steiner
et al [28] with the increase in total renal blood flow
of approximately 40% induced by saralasin ob-
served in our studies, it appears that redistribution
of blood flow to nonsuperficial gbomeruli probably
also occurred in their studies. This suggests that the
changes in glomerular blood flow distribution pres-
ently observed are not likely to result from rheobog-
ic effects of renal vasodilatation.
Mechanisms underlying the redistribution of re-
nal blood flow toward deep cortex during pharma-
cologic inhibition of the renin-angiotensin system
include the fall in arterial pressure, renal vasodilata-
tion itself, and inhibition of the tonic effect of an-
giotensin II on gbomerular vessels by saralasin and
converting enzyme inhibition. In the rat and using
microspheres and a microdissection technique,
Källskog et al observed that a decrease in renal per-
fusion pressure [29], as well as nonhypotensive in-
fusion of acetylcholine or bradykinin [30], results in
a shift of blood flow from superficial to deeper
glomeruli. Similar observations were reported in
dogs [31]. Whether these changes in glomerular
blood flow distribution are related to vasodilatation
itself, inhibition of angiotensin, or the fall in arteri-
al pressure remains unclarified.
In the present investigation, saralasin and acute
captopril administration were associated with simi-
lar effects on arterial pressure and plasma renin ac-
tivity (Fig. 2), renal blood flow and its intrarenal dis-
tribution (Table 1 and Fig. 3), and GFR and urinary
sodium excretion (Table 2). These findings are in
agreement with those made in anesthetized sodium-
depleted rabbits [4] and conscious dogs [19]. Re-
cently, it was demonstrated that tubulogbomerular
feedback is equally inhibited by saralasin [32] and
the converting enzyme inhibitor SQ 20,881 [33].
Taken together, these observations suggest that
captopril may act solely through inhibition of the
renin-angiotensin system, at least in the rat.
In opposition tO the lack of natriuresis following
acute captopril administration in the anesthetized
rat, chronic converting enzyme inhibition induced a
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rapid and substantial increase in water and sodium
excretion. In addition, a progressive decrease in
urinary aldosterone excretion occurred, and urinary
kallikrein did not change (preliminary results); the
changes in sodium output were not related, how-
ever, to the fall in aldosterone, a finding that sug-
gests that natriuresis might be, at least in part, a
consequence of the removal of angiotensin' s effect
on renal tubular function. The lack of decrease in
kaliikrein excretion during the decrease in urinary
aidosterone remains unexplained because a positive
correlation between these two paramaters has been
observed [13, 14]. Nevertheless, this could be an
additional argument against an influence of kinins in
the chronic effect of captopril because accumula-
tion of kinins might be expected to result in a de-
crease in urinary kailikrein through a negative feed-
back regulation of kinins on kidney kallikrein re-
lease [8].
In conclusion, the results of the present study
suggest that inhibition of the renin-angiotensin sys-
tern is the sole action of captopril. In addition, they
indicate that removal of the effect of endogenous
angiotensin in chronically sodium-depleted rats re-
suits in a shift of blood flow toward nonsuperficial
glomeruli. Nevertheless, this observation requires
confirmation, for one should be cautious in inter-
preting data obtained with the microsphere method.
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